A Phase Ib/II Study to Evaluate Surufatinib Combined with Camrelizumab and Chemotherapy in the Second-Line Treatment of Advanced Colorectal Cancer: Phase Ib Results
JOURNAL OF CLINICAL ONCOLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined